Literature DB >> 1736573

Compensatory and noncompensatory left ventricular dilatation after myocardial infarction: time course and hemodynamic consequences at rest and during exercise.

P Gaudron1, C Eilles, G Ertl, K Kochsiek.   

Abstract

Survival after myocardial infarction decreases with left ventricular dilatation, although dilatation at 4 weeks was found to be compensatory. To study this apparent discrepancy, prospective simultaneous volume and hemodynamic measurements at rest were extended in 39 patients with small and 37 with large myocardial infarctions from 4 (range 2 to 6) days and 4 (range 3 to 5) weeks to 6 (range 5 to 8) months after myocardial infarction and were repeated during exercise. In small myocardial infarctions, end-diastolic volume index (EDVI) decreased from 4 days to 6 months; ejection fraction, stroke volume index (SVI), and end-systolic volume index (ESVI) remained unchanged. SVI increased during exercise at 4 weeks and at 6 months. In large myocardial infarctions (n = 37) ESVI (4 days = 38 +/- 3, 4 weeks = 47 +/- 3,* 6 months = 52 +/- 3*; *p less than 0.05 versus 4 days) and EDVI (4 days = 72 +/- 3, 4 weeks = 86 +/- 5,* 6 months = 92 +/- 5* ; *p less than 0.05 versus 4 days and p less than 0.05 versus 4 weeks) increased at constant wedge pressure. SVI remained unchanged beyond 4 weeks (4 days = 35 +/- 2, 4 weeks = 42 +/- 2*, 6 months = 42 +/- 2*; *p less than 0.05 versus 4 days) and increased during exercise at 4 weeks (rest = 45 +/- 2, exercise = 55 +/- 3; p less than 0.05) but not at 6 months (rest = 42 +/- 3, exercise = 45 +/- 3; p = NS).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1736573     DOI: 10.1016/0002-8703(92)90649-g

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

1.  Ventricular dilatation in the absence of ACE inhibitors: influence of haemodynamic and neurohormonal variables following myocardial infarction.

Authors:  J T Walsh; P D Batin; M Hawkins; D McEntegart; A J Cowley
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

2.  Arterial stiffness as a predictor of recovery of left ventricular systolic function after acute myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Egidio Imbalzano; Marco Vatrano; Giuseppe Mandraffino; Lorenzo Ghiadoni; Sebastiano Gangemi; Rosa Maria Bruno; Vincenzo Antonio Ciconte; Nevena Paunovic; Rossella Costantino; Enrico Maria Mormina; Roberto Ceravolo; Antonino Saitta; Giuseppe Dattilo
Journal:  Int J Cardiovasc Imaging       Date:  2015-08-04       Impact factor: 2.357

Review 3.  Angiotensin converting enzyme inhibitors in angina and myocardial infarction. What role will they play in the 1990s?

Authors:  G Ertl
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

Review 4.  Interfacial tissue engineering of heart regenerative medicine based on soft cell-porous scaffolds.

Authors:  Xiwen Geng; Bing Liu; Jiaqing Liu; Dong Liu; Yupeng Lu; Xiaotian Sun; Kang Liang; Biao Kong
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 5.  Tissue Engineering Strategies for Myocardial Regeneration: Acellular Versus Cellular Scaffolds?

Authors:  Maribella Domenech; Lilliana Polo-Corrales; Jaime E Ramirez-Vick; Donald O Freytes
Journal:  Tissue Eng Part B Rev       Date:  2016-07-21       Impact factor: 6.389

6.  Management of mitral regurgitation during left ventricular reconstruction for ischemic heart failure.

Authors:  Patrick Klein; Jerry Braun; Eduard R Holman; Michel I M Versteegh; Harriette F Verwey; Robert A E Dion; Jeroen J Bax; Robert J M Klautz
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

7.  Surgical ventricular restoration: an operation to reverse remodeling - the basic science (part I).

Authors:  Ganesh Shanmugam; Imtiaz S Ali
Journal:  Curr Cardiol Rev       Date:  2009-11

Review 8.  The last frontier: transcatheter devices for percutaneous or minimally invasive treatment of chronic heart failure.

Authors:  V J Nijenhuis; L Sanchis; J A S van der Heyden; P Klein; B J W M Rensing; A Latib; F Maisano; J M Ten Berg; P Agostoni; M J Swaans
Journal:  Neth Heart J       Date:  2017-10       Impact factor: 2.380

9.  Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy.

Authors:  Jennifer J Rayner; Ines Abdesselam; Joanna d'Arcy; Saul G Myerson; Stefan Neubauer; Hugh Watkins; Vanessa M Ferreira; Oliver J Rider
Journal:  Cardiovasc Diagn Ther       Date:  2020-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.